> INVESTIGATORS
Meet Our Principal Investigators
Dedicated Investigators Advancing Clinical Research and Patient Care.
RMP continues to expand its network of investigators, research sites, and specialty practices to support Sponsors and CROs across a broad range of therapeutic areas.
Rogelio O. Bardinas, MD, FAAFP
Principal Investigator | Family Medicine
Dr. Rogelio O. Bardinas Rodriguez is a board-certified Family Medicine physician serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network.
With more than three decades of clinical and research experience, Dr. Bardinas has developed extensive expertise in primary care medicine, multidisciplinary clinical practice, and the execution of industry-sponsored clinical trials across multiple therapeutic areas.
Throughout his career, Dr. Bardinas has held several leadership positions in healthcare institutions, including serving as Medical Director for outpatient medical centers and leading multidisciplinary clinical teams responsible for delivering comprehensive patient care. His background also includes specialized training in orthopedic and trauma surgery, as well as experience managing complex musculoskeletal conditions and chronic disease populations.
Dr. Bardinas has extensive experience serving as both Principal Investigator and Sub-Investigator in Phase II–IV clinical trials sponsored by pharmaceutical companies and research organizations. His clinical research work spans a wide range of therapeutic areas including respiratory diseases, diabetes, cardiovascular conditions, infectious diseases, oncology screening, chronic pain management, and neurological disorders.
This diverse research portfolio reflects his ability to manage complex study populations and support the development of innovative medical therapies.
Within the RMP clinical research network, Dr. Bardinas operates under a structured operational framework that integrates site-level clinical expertise with centralized regulatory oversight, standardized operating procedures, and sponsor-aligned governance. In this role, he is responsible for overseeing protocol implementation, patient safety monitoring, study participant evaluations, and ensuring strict adherence to regulatory and ethical standards throughout the clinical trial process.
Dr. Bardinas completed his medical education at the Instituto Superior de Ciencias Médicas in Havana, Cuba, and later completed residency training in Family Medicine in the United States. Earlier in his career, he also completed specialized training in orthopedic and trauma surgery, including advanced fellowships and surgical courses in orthopedic trauma and hand surgery. His international medical experience has allowed him to work in diverse healthcare systems and academic environments.
In addition to his clinical and research activities, Dr. Bardinas has contributed to academic medicine through multiple medical presentations and educational conferences covering topics such as cardiovascular disease, orthopedic trauma, obstetrics-related complications, and geriatric medicine. His commitment to medical education and clinical excellence has remained a consistent theme throughout his professional career.
Dr. Bardinas conducts his research activities in full compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP clinical research network, he supports sponsors and CRO partners in the successful execution of high-quality clinical trials while helping expand patient access to innovative therapies across multiple medical specialties.
Rogelio O. Bardinas, MD, FAAFP
Principal Investigator | Family Medicine
Dr. Rogelio O. Bardinas Rodriguez is a board-certified Family Medicine physician serving as a Principal Investigator within the Research Management Partners (RMP) Site Management Organization network.
With more than three decades of clinical and research experience, Dr. Bardinas has developed extensive expertise in primary care medicine, multidisciplinary clinical practice, and the execution of industry-sponsored clinical trials across multiple therapeutic areas.
Throughout his career, Dr. Bardinas has held several leadership positions in healthcare institutions, including serving as Medical Director for outpatient medical centers and leading multidisciplinary clinical teams responsible for delivering comprehensive patient care. His background also includes specialized training in orthopedic and trauma surgery, as well as experience managing complex musculoskeletal conditions and chronic disease populations.
Dr. Bardinas has extensive experience serving as both Principal Investigator and Sub-Investigator in Phase II–IV clinical trials sponsored by pharmaceutical companies and research organizations. His clinical research work spans a wide range of therapeutic areas including respiratory diseases, diabetes, cardiovascular conditions, infectious diseases, oncology screening, chronic pain management, and neurological disorders.
This diverse research portfolio reflects his ability to manage complex study populations and support the development of innovative medical therapies.
Within the RMP clinical research network, Dr. Bardinas operates under a structured operational framework that integrates site-level clinical expertise with centralized regulatory oversight, standardized operating procedures, and sponsor-aligned governance. In this role, he is responsible for overseeing protocol implementation, patient safety monitoring, study participant evaluations, and ensuring strict adherence to regulatory and ethical standards throughout the clinical trial process.
Dr. Bardinas completed his medical education at the Instituto Superior de Ciencias Médicas in Havana, Cuba, and later completed residency training in Family Medicine in the United States. Earlier in his career, he also completed specialized training in orthopedic and trauma surgery, including advanced fellowships and surgical courses in orthopedic trauma and hand surgery. His international medical experience has allowed him to work in diverse healthcare systems and academic environments.
In addition to his clinical and research activities, Dr. Bardinas has contributed to academic medicine through multiple medical presentations and educational conferences covering topics such as cardiovascular disease, orthopedic trauma, obstetrics-related complications, and geriatric medicine. His commitment to medical education and clinical excellence has remained a consistent theme throughout his professional career.
Dr. Bardinas conducts his research activities in full compliance with international and U.S. regulatory standards, including ICH-GCP guidelines, FDA regulations, and Institutional Review Board (IRB) requirements. Through his participation in the RMP clinical research network, he supports sponsors and CRO partners in the successful execution of high-quality clinical trials while helping expand patient access to innovative therapies across multiple medical specialties.
Iliana Acosta, MD
Principal Investigator | Internal Medicine
Dr. Ileana Acosta is a Florida-licensed physician serving as a Principal Investigator within the Research Management Partners (RMP) network, bringing over three decades of clinical experience and a proven track record in the execution of industry-sponsored clinical trials.
Operating within an embedded clinical research environment at Gables Medical Center in Miami, Dr. Acosta combines active patient care with structured research delivery—ensuring seamless integration of protocol requirements into real-world clinical practice. This model supports consistent patient access, high retention rates, and reliable study execution.
Dr. Acosta has contributed to multiple Phase II–IV clinical trials, including randomized, double-blind, placebo-controlled and multi-center studies across key therapeutic areas such as respiratory diseases, cardiovascular and metabolic disorders, infectious diseases (including COVID-19 prevention), and rare conditions. Her experience includes participation in advanced therapeutic protocols evaluating novel agents, biologics, and long-term safety and efficacy outcomes.
Through her role in clinical research, Dr. Acosta demonstrates strong operational discipline, adherence to ICH-GCP standards, and the ability to support high-quality data generation under demanding protocol conditions. Her involvement in complex studies requiring strict compliance, patient monitoring, and longitudinal follow-up reflects a high level of reliability from both an investigator and site performance perspective.
Dr. Acosta’s extensive clinical background—spanning internal medicine, OB/GYN, and primary care—enables her to manage diverse and often underserved patient populations, supporting enrollment efficiency and protocol adherence across a wide range of indications.
As part of the RMP embedded SMO model, Dr. Acosta operates under standardized SOPs, continuous on-site quality control, and centralized oversight—ensuring audit readiness, reduced protocol deviations, and consistent performance aligned with sponsor expectations.
She holds active medical licensure in Florida and Puerto Rico, is ECFMG certified, and maintains continuous medical education to support both her clinical and research responsibilities.
Iliana Acosta, MD
Principal Investigator | Internal Medicine
Dr. Ileana Acosta is a Florida-licensed physician serving as a Principal Investigator within the Research Management Partners (RMP) network, bringing over three decades of clinical experience and a proven track record in the execution of industry-sponsored clinical trials.
Operating within an embedded clinical research environment at Gables Medical Center in Miami, Dr. Acosta combines active patient care with structured research delivery—ensuring seamless integration of protocol requirements into real-world clinical practice. This model supports consistent patient access, high retention rates, and reliable study execution.
Dr. Acosta has contributed to multiple Phase II–IV clinical trials, including randomized, double-blind, placebo-controlled and multi-center studies across key therapeutic areas such as respiratory diseases, cardiovascular and metabolic disorders, infectious diseases (including COVID-19 prevention), and rare conditions. Her experience includes participation in advanced therapeutic protocols evaluating novel agents, biologics, and long-term safety and efficacy outcomes.
Through her role in clinical research, Dr. Acosta demonstrates strong operational discipline, adherence to ICH-GCP standards, and the ability to support high-quality data generation under demanding protocol conditions. Her involvement in complex studies requiring strict compliance, patient monitoring, and longitudinal follow-up reflects a high level of reliability from both an investigator and site performance perspective.
Dr. Acosta’s extensive clinical background—spanning internal medicine, OB/GYN, and primary care—enables her to manage diverse and often underserved patient populations, supporting enrollment efficiency and protocol adherence across a wide range of indications.
As part of the RMP embedded SMO model, Dr. Acosta operates under standardized SOPs, continuous on-site quality control, and centralized oversight—ensuring audit readiness, reduced protocol deviations, and consistent performance aligned with sponsor expectations.
She holds active medical licensure in Florida and Puerto Rico, is ECFMG certified, and maintains continuous medical education to support both her clinical and research responsibilities.
Biospecimen Collection & Laboratory Partnerships
RMP collaborates with experienced laboratory partners supporting:
-
Blood Collection
-
Tissue Collection
-
PBMC Processing
-
Biomarker Analysis
-
Genomic Testing
-
Sample Processing & Storage
-
Chain of Custody Management
-
Protocol-Specific Laboratory Workflows
Style 3: SLIDER Title Investigator Category
(Please advise if keeping all 3 CTA'S or 1 specific for each page)
Let’s Talk About Your Next Oncology Program
Why Sponsors Choose RMP
Our dedicated research teams work closely with Sponsors and CROs to support:
-
Access to Oncology Patients
-
Integrated Clinical Workflows
-
Biospecimen Collection Support
-
Centralized Quality Oversight
-
Multi-Site Scalability
-
Experienced Investigators
Style 2: Title Investigator Category